Human chorionic gonadotropin in pregnancy diagnostics

Clinica Chimica Acta

Volumn 412, Issue 17-18, 2011, Pages 1515-1520

  Montagnana, Martina ^a   Trenti, Tommaso ^b,d   Aloe, Rosalia ^c,d   Cervellin, Gianfranco ^c   Lippi, Giuseppe ^c,d  

^a UNIVERSITY OF VERONA   (Italy)

^b AUSL Modena   (Italy)

^c UNIVERSITY HOSPITAL OF PARMA   (Italy)

^d Area Vasta Emilia Nord ^*  (Italy)

Author keywords

HCG; Human chorionic gonadotropin; Pregnancy; Testing

Indexed keywords

CHORIONIC GONADOTROPIN;

CLINICAL ASSESSMENT; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; GONADOTROPIN BLOOD LEVEL; HORMONE DETERMINATION; HORMONE SYNTHESIS; HORMONE URINE LEVEL; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; NONHUMAN; PREGNANCY OUTCOME; PREGNANCY TEST; PRENATAL SCREENING; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS; URINALYSIS;

CHORIONIC GONADOTROPIN; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; IMMUNOASSAY; PREGNANCY;

EID: 79959297529     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.05.025     Document Type: Review

References (82)

1. Hirose T. Exogenous stimulation of corpus luteum formation in the rabbit: influence of extracts of human placenta, decidua, fetus, hydatid mole, and corpus luteum on the rabbit gonad. J Jpn Gynecol Soc 1920, 16:1055.
2. Lapthorn A.J., Harris D.C., Littlejohn A., et al. Crystal structure of human chorionic gonadotropin. Nature 1994, 369:455-461.
3. Marcillac I., Troalen F., Bidart J.-M., et al. Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms. Cancer Res 1992, 52:3901-3907.
4. Alfthan H., Haglund C., Dabek J., Stenman U.H. Concentrations of human choriogonadotropin, its beta-subunit, and the core fragment of the beta-subunit in serum and urine of men and nonpregnant women. Clin Chem 1992, 38:1981-1987.
5. Butler S.A., Khanlian S.A., Cole L.A. Detection of early pregnancy forms of human chorionic gonadotropin by home pregnancy test devices. Clin Chem 2001, 47:2131-2136.
6. Stenman U.H., Tiitinen A., Alfthan H., Valmu L. The classification, functions and clinical use of different isoforms of HCG. Hum Reprod Update 2006, 12:769-784.
7. Stenman U.-H., Bidart J.M., Birken S., Mann K., Nisula B., O'Connor J. Standardization of protein immunoprocedures. Choriogonadotropin (CG) Scand J Clin Lab Invest Suppl 1993, 216:42-78.
8. National Committee for Clinical Laboratory Standards Choriogonadotropin testing: nomenclature, reference preparations, assay performance, and clinical application; approved guideline. NCCLS Wayne, PA 1996, NCCLS Document I/LA10-A.
9. Bower B., Moore R., Schwartz M. Endocrine function and carbohydrates, tumor markers. Clinical laboratory medicine 2002, 329-330. Lippincott Williams and Wilkins, Philadelphia, 491. 2nd ed. K. McClatchey (Ed.).
10. Ascheim S., Zondek B. Das Hormon des Hypophysenvorderlappens: testobjekt zum nachweis des hormons. Klin Wochenschr 1927, 6:248-252.
11. Wide L., Gemzell C.A. An immunological pregnancy test. Acta Endocrinol (Copenh) 1960, 35:261-267.
12. Odell W.D., Ross G.T., Rayford P.L. Radioimmunoassay for luteinizing hormone in human plasma and serum: physiological studies. J Clin Invest 1967, 46:248-255.
13. Vaitukaitis J.L., Braunstein G.D., Ross G.T. A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone. Am J Obstet Gynecol 1972, 113:751-758.
14. Bidart J.M., Ozturk M., Bellet D.H., et al. Identification of epitopes associated with hCG and beta hCG carboxyl-terminus by monoclonal antibodies produced against a synthetic peptide. J Immunol 1985, 134:457-464.
15. Hussa R.O., Hudson En A two-site immunometric assay in evaluation of low levels of serum hCG. Am Clin Prod Rev 1984, 3:12-17.
16. Palmieri C., Dhillon T., Fisher R.A., et al. Management and outcome of healthy women with a persistently elevated beta-hCG. Gynecol Oncol 2007, 106:35-43.
17. Snyder J.A., Haymond S., Parvin C.A., Gronowski A.M., Grenache D.G. Diagnostic considerations in the measurement of human chorionic gonadotropin in aging women. Clin Chem 2005, 51:1830-1835.
18. Bristow A., Berger P., Bidart J.M., et al. IFCC Working Group on hCG. Establishment, value assignment, and characterization of new WHO reference reagents for six molecular forms of human chorionic gonadotropin. Clin Chem 2005, 51:177-182.
19. Berger P., Sturgeon C., Bidart J.M., et al. The ISOBM TD-7 Workshop on hCG and related molecules. Towards user-oriented standardization of pregnancy and tumor diagnosis: assignment of epitopes to the three-dimensional structure of diagnostically and commercially relevant monoclonal antibodies directed against human chorionic gonadotropin and derivatives. Tumour Biol 2002, 23:1-38.
20. Olsen T.G., Barnes A.A., King J.A. Elevated HCG outside of pregnancy-diagnostic considerations and laboratory evaluation. Obstet Gynecol Surv 2007, 62:669-674.
21. Cole L.A. Immunoassay of human chorionic gonadotropin, its free subunits, and metabolites. Clin Chem 1997, 43:2233-2243.
22. Birken S., Berger P., Bidart J.M., et al. Preparation and characterization of new WHO reference reagents for human chorionic gonadotropin and metabolites. Clin Chem 2003, 49:144-154.
23. Gronowski A.M., Grenache D.G. Characterization of the hCG variants recognized by different hCG immunoassays: an important step toward standardization of hCG measurements. Clin Chem 2009, 55:1447-1449.
24. Shields A. Pregnancy diagnosis http://emedicine.medscape.com/article/262591-overview.
25. Whittington J., Fantz C.R., Gronowski A.M., et al. The analytical specificity of human chorionic gonadotropin assays determined using WHO International Reference Reagents. Clin Chim Acta 2010, 411:81-85.
26. Kato Y., Braunstein G.D. Beta-core fragment is a major form of immunoreactive urinary chorionic gonadotropin in human pregnancy. J Clin Endocrinol Metab 1988, 66:1197-1201.
27. Braunstein G.D. False-positive serum human chorionic gonadotropin results: causes, characteristics, and recognition. Am J Obstet Gynecol 2002, 187:217-224.
28. Cole L.A., Rinne K.M., Shahabi S., Omrani A. False-positive hCG assay results leading to unnecessary surgery and chemotherapy and needless occurrences of diabetes and coma. Clin Chem 1999, 45:313-314.
29. King I.R., Doody M.C. False-positive hCG by enzyme immunoassay resulting in repeated chemotherapy. Obstet Gynecol 1995, 86:682-683.
30. Cole L.A., Shahabi S., Butler S.A., et al. Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases. Clin Chem 2001, 47:308-315.
31. Cole L.A., Wang Y., Elliott M., et al. Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancers. Cancer Res 1988, 48:1356-1360.
32. Alfthan H., Haglund C., Roberts P., Stenman U.H. Elevation of free beta-subunit of human choriogonadotropin and core β fragment of human choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease. Cancer Res 1992, 52:4628-4633.
33. Syrigos K.N., Fyssas I., Konstandoulakis M.M., et al. Beta human chorionic gonadotropin concentrations in serum of patients with pancreatic adenocarcinoma. Gut 1998, 42:88-91.
34. Sheaff M.T., Martin J.E., Badenoch D.F., Baithun S.I. Beta hCG as a prognostic marker in adenocarcinoma of the prostate. J Clin Pathol 1996, 49:329-332.
35. Lundin M., Nordling S., Carpelan-Holmstrom M., et al. A comparison of serum and tissue hCG beta as prognostic markers in colorectal cancer. Anticancer Res 2000, 20:4949-4952.
36. Sato S., Ishii M., Fujihira T., Ito E., Ohtani Y. Gallbladder adenocarcinoma with human chorionic gonadotropin: a case report and review of literature. Diagn Pathol 2010, 5:46.
37. Tageja N., Valent J., Giorgadze T., Bentley G., Zonder J. Positive pregnancy tests in a postmenopausal woman due to beta-human chorionic gonadotropin production by multiple myeloma. Am J Med Sci 2010, 339:182-184.
38. Slone S.P., Ahmed Z., Cole L.A., et al. Positive pregnancy tests in a nongravid, premenopausal woman due to hCG beta-chain production by multiple myeloma. Am J Clin Pathol 2005, 124:108-112.
39. Collins R.J., Wong L.C. Adenocarcinoma of the uterine cervix with beta-hCG production: a case report and review of the literature. Gynecol Oncol 1989, 33:99-107.
40. Reisenbichler E.S., Krontiras H., Hameed O. Beta-human chorionic gonadotropin production associated with phyllodes tumor of the breast: an unusual paraneoplastic phenomenon. Breast J 2009, 15:527-530.
41. Vladutiu A.O., Sulewski J.M., Pudlak K.A., Stull C.G. Heterophilic antibodies interfering with radioimmunoassay. A false-positive pregnancy test. JAMA 1982, 248:2489-2490.
42. Check J.H., Nowroozi K., Chase J.S., Lauer C., Elkins B., Wu C.H. False-positive human chorionic gonadotropin levels caused by a heterophile antibody with the immunoradiometric assay. Am J Obstet Gynecol 1988, 158:99-100.
43. Cole L.A., Khanlian S.A. Easy fix for clinical laboratories for the false-positive defect with the Abbott AxSym total beta-hCG test. Clin Biochem 2004, 37:344-349.
44. Rotmensch S., Cole L.A. False diagnosis and needless therapy of presumed malignant disease in women with false-positive human chorionic gonadotropin concentrations. Lancet 2000, 355:712-715.
45. ACOG Committee on Gynecologic Practice Avoiding inappropriate clinical decisions based on false-positive human chorionic gonadotropin test results. Int J Gynaecol Obstet 2003, 80:231-233.
46. Esfandiari N., Goldberg J.M. Heterophile antibody blocking agent to confirm false positive serum human chorionic gonadotropin assay. Obstet Gynecol 2003, 101:1144-1146.
47. Selby C. Interference in immunoassay. Ann Clin Biochem 1999, 36:704-721.
48. Fahy B.G., Gouzd V.A., Atallah J.N. Pregnancy tests with end-stage renal disease. J Clin Anesth 2008, 20:609-613.
49. Buckner C.L., Wilson L., Papadea C.N. An unusual cause of elevated serum total beta hCG. Ann Clin Lab Sci 2007, 37:186-191.
50. Schwarz A., Post K.G., Keller F., Molzahn M. Value of human chorionic gonadotropin measurements in blood as a pregnancy test in women on maintenance hemodialysis. Nephron 1985, 39:341-343.
51. Pimstone B., Epstein S., Hamilton S.M., LeRoith D., Hendricks S. Metabolic clearance and plasma half disappearance time of exogenous gonadotropin releasing hormone in normal subjects and in patients with liver disease and chronic renal failure. J Clin Endocrinol Metab 1977, 44:356-360.
52. Hubinont C.J., Goldman M., Vanherweghem J.L., Schwers J. Effects of chronic renal failure and hemodialysis on hormonal evaluation of pregnancy. Am J Nephrol 1988, 8:57-61.
53. Orlandi F., Rossi C., Allegra A., et al. First trimester screening with free beta-hCG, PAPP-A and nuchal translucency in pregnancies conceived with assisted reproduction. Prenat Diagn 2002, 22:718-721.
54. Delbeke F.T., Van Eenoo P., De Backer P. Detection of human chorionic gonadotrophin misuse in sports. Int J Sports Med 1998, 19:287-290.
55. Stenman U.H., Hotakainen K., Alfthan H. Gonadotropins in doping: pharmacological basis and detection of illicit use. Br J Pharmacol 2008, 154:569-583.
56. Robinson N., Sottas P.E., Saugy M. Evaluation of two immunoassays for the measurement of human chorionic gonadotropin in urine for anti-doping purposes. Clin Lab 2010, 56:197-206.
57. Kruskall M.S., Owings D.V., Donovan L.M., Pacini D.G., Costello T.J. Passive transfusion of human chorionic gonadotropin from plasma donated during pregnancy. Vox Sang 1989, 56:71-74.
58. Shelat S.G., Friedman D.F., Meny G.M., Smith-Whitley K., Carlow D., Norris R. False-positive pregnancy test after passive transfusion of beta-human chorionic gonadotropin from donor red blood cells during erythrocytapheresis. Transfusion 2007, 47:788-791.
59. Grenache D.G., Greene D.N., Dighe A.S., et al. Falsely decreased human chorionic gonadotropin (hCG) results due to increased concentrations of the free beta subunit and the beta core fragment in quantitative hCG assays. Clin Chem 2010, 56:1839-1844.
60. Greene D.N., Hall B.J., Grenache D.G. An unlikely pregnancy. Clin Chem 2010, 56:1645-1646.
61. Al-Mahdili H.A., Jones G.R. High-dose hook effect in six automated human chorionic gonadotrophin assays. Ann Clin Biochem 2010, 47:383-385.
62. Levavi H., Neri A., Bar J., Regev D., Nordenberg J., Ovadia J. "Hook effect" in complete hydatidiform molar pregnancy: a falsely low level of beta-HCG. Obstet Gynecol 1993, 82:720-721.
63. Cervinski M.A., Lockwood C.M., Ferguson A.M., et al. Qualitative point-of-care and over-the-counter urine hCG devices differentially detect the hCG variants of early pregnancy. Clin Chim Acta 2009, 406:81-85.
64. Levsky M.E., Handler J.A., Suarez R.D., Esrig E.T. False-positive urine beta-HCG in a woman with a tubo-ovarian abscess. J Emerg Med 2001, 21:407-409.
65. Kountz D.S., Kolander S.A., Rozovsky A. False positive pregnancy test in the nephrotic syndrome. N Engl J Med 1989, 321:1416.
66. Cadoff E., Daniel A. Effect of urinary proteins on in vitro immunological tests for pregnancy. Am J Med Technol 1983, 49:173-176.
67. Cole L.A., Laidler L.L. Inherited human chorionic gonadotropin. J Reprod Med 2010, 55:99-102.
68. Chard T. Pregnancy tests: a review. Hum Reprod 1992, 7:701-710.
69. Kalinski M.A., Guss D.A. Hemorrhagic shock from a ruptured ectopic pregnancy in a patient with a negative urine pregnancy test result. Ann Emerg Med 2002, 40:102-105.
70. Barnes R.B., Roy S., Yee B., Duda M.J., Mishell D.R. Reliability of urinary pregnancy tests in the diagnosis of ectopic pregnancy. J Reprod Med 1985, 30:827-831.
71. Bozoklu S., Bozoklu E., Ciftci A., Coskun T. Ruptured ectopic pregnancy with undetectable beta-hCG levels coexisting with acute appendicitis. Acta Obstet Gynecol Scand 1997, 76:181-182.
72. Lonky N.M., Sauer M.V. Ectopic pregnancy with shock and undetectable β human chorionic gonadotropin: a case report. J Reprod Med 1987, 32:559-560.
73. Maccato M.L., Estrada R., Faro S. Ectopic pregnancy with undetectable serum and urine beta-hCG levels and detection of beta-hCG in the ectopic trophoblast by immunocytochemical evaluation. Obstet Gynecol 1993, 81:878-880.
74. Olson C.M., Holt J.A., Alenghat E., Greco S., Lumpkin J.R., Geanon G.D. Limitations of qualitative serum beta-hCG assays in the diagnosis of ectopic pregnancy. J Reprod Med 1983, 28:838-842.
75. Taylor R.N., Padula C., Goldsmith P.C. Pitfall in the diagnosis of ectopic pregnancy: immunocytochemical evaluation in a patient with false-negative serum β-hCG levels. Obstet Gynecol 1988, 71:1035-1038.
76. Ikomi A., Matthews M., Kuan A.M., Henson G. The effect of physiological urine dilution on pregnancy test results in complicated early pregnancies. Br J Obstet Gynaecol 1998, 105:462-465.
77. Pang Y.P., Rajesh H., Tan L.K. Molar pregnancy with false negative urine hCG: the hook effect. Singapore Med J 2010, 51:e58-e61.
78. Davison C.M., Kaplan R.M., Wenig L.N., Burmeister D. Qualitative beta-hCG urine assays may be misleading in the presence of molar pregnancy: a case report. J Emerg Med 2004, 27:43-47.
79. Meyer T., Cole L.A., Richman P.I., Mitchell H.D., Myers J., Rustin G.J. High levels of hCG in choriocarcinoma can result in renal failure and a false-negative pregnancy test in men. Clin Oncol (R Coll Radiol) 2001, 13:301-303.
80. Gronowski A.M., Cervinski M., Stenman U.H., Woodworth A., Ashby L., Scott M.G. False-negative results in point-of-care qualitative human chorionic gonadotropin (hCG) devices due to excess hCGbeta core fragment. Clin Chem 2009, 55:1389-1394.
81. Stricklan T.W., Puett D. Contribution of subunits to the function of luteinizing hormone/human chorionic gonadotropin recombinants. Endocrinology 1981, 109:1933-1942.
82. Papapetrou P.D., Nicopoulou S.C. The origin of a human chorionic gonadotropin-subunit-core fragment excreted in the urine of patients with cancer. Acta Endocrinol 1986, 112:415-422.